Responses
Immune cell therapies and immune cell engineering
Original research
Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies: a phase I/II study
Compose a Response to This Article
Other responses
No responses have been published for this article.
